Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in Solid Tumor Patients With Stable Third-Space Fluid
NCT00316225Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of pemetrexed in non-small cell lung cancer (NSCLC), mesothelioma, sponsored by Eli Lilly and Company. Started Dec 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)mesothelioma
Beyond the preview
Go deeper on NCT00316225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316225.